Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 32, 1905-1911, September 1, 1972]
© 1972 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Wijk, R.
Right arrow Articles by Clay, K.
Right arrow Search for Related Content
PubMed
Right arrow Articles by van Wijk, R.
Right arrow Articles by Clay, K.

Effects of Derivatives of Cyclic 3',5'-Adenosine Monophosphate on the Growth, Morphology, and Gene Expression of Hepatoma Cells in Culture1

Roeland van Wijk2, Wesley D. Wicks and Keith Clay

Division of Research, National Jewish Hospital and Research Center [R. V. W., W. D. W.], and Department of Pharmacology, University of Colorado School of Medicine [K. C.], Denver, Colorado 80206

The growth rate of Reuber H35 hepatoma cells in monolayer culture has been shown to be inhibited by N6,O2'-dibutyryl cyclic 3',5'-adenosine monophosphate (DBcAMP). The effect is concentration dependent and readily reversible. Other adenine nucleotides are inactive at concentrations at which DBcAMP is active or cause release of cells into the medium and subsequent cell death at high concentrations. DBcAMP also exhibits similar toxicity at high concentrations, but only DBcAMP and two 8-thio derivatives of cyclic 3',5'-adenosine monophosphate appreciably reduce the growth of attached cells at any concentration. Cells grown in the presence of DBcAMP are larger and also possess characteristic long, narrow processes. HTC hepatoma cells do not exhibit any of these specific responses to DBcAMP, but they do show a nonspecific toxic response with high concentrations of DBcAMP and adenine nucleotides. Among the derivatives of cyclic 3',5'-adenosine monophosphatetested, only those that are effective inducers of tyrosine transaminase are capable of inhibiting the growth of attached H35 cells. The rate of protein synthesis was not inhibited by growth of H35 cells in the presence of DBcAMP and the content of protein was greater in the treated cells. In contrast, DNA synthesis was markedly inhibited shortly after the addition of DBcAMP. It is concluded that DBcAMP and certain derivatives of cyclic 3',5'-adenosine monophosphate are capable of specifically and reversibly inhibiting the growth of H35 hepatoma cells in culture.

1 This work was supported by the Netherlands Organization for the Advancement of Pure Research (Z. W. O.), by Grant AM 14601 from the NIH, USPHS, and by General Research Support Grant RR 05474 to National Jewish Hospital from the same agency.

2 On leave of absence from Van't Hoff Laboratory, State University, Utrecht, The Netherlands.

Received 2/18/72. Accepted 6/ 1/72.




This article has been cited by other articles:


Home page
ScienceHome page
Y. S. Cho-Chung and P. M. Gullino
In vivo Inhibition of Growth of Two Hormone-Dependent Mammary Tumors by Dibutyryl Cyclic AMP
Science, January 11, 1974; 183(4120): 87 - 88.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1972 by the American Association for Cancer Research.